XYLO logo

Xylo Technologies (XYLO) Company Overview

Profile

Full Name:

Xylo Technologies

Sector:

Healthcare

Industry:

Medical Devices

Country:

Israel

IPO:

Indexes:

Not included

Website:

http://www.medigus.com

Description:

Xylo Technologies is a company that provides innovative software solutions and technology services to help businesses improve their operations and efficiency.

Key Details

Price

$4.91

Market Cap

$3.59 M(Small cap)

Last Dividend

$2.27

TTM Dividend Yield

-

Annual Revenue

$91.72 M(-0.15% YoY)

Annual EPS

-$25.20(-57.50% YoY)

PE Ratio

-

Annual ROE

-36.79%

Annual Debt To Equity

0.39

Beta

1.68

Events Calendar

Earnings

Next earnings date:

N/A

Recent quarterly earnings:

Feb 28, 2025

Recent annual earnings:

Feb 28, 2025
Dividend

Next ex-dividend date:

N/A

Recent ex-dividend date:

Dec 19, 2022
Splits

Next split:

N/A

Recent split:

Aug 5, 2024

Analyst ratings

Recent major analysts updates

No data about analysts updates

Screeners with XYLO included

Growing Shares Outstanding
Stocks with high beta
Best performing stocks last 3 months
Healthcare sector
All stocks
Biggest stock gainers today
Stocks above SMA 50
Small cap stocks
Israeli stocks
Medical Devices industry

Market Data

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Price

Current Price

$4.91
XYLO price is $4.91

Price All-time High

$8000.00
XYLO price is currently -99.94% below its historical high of $8000.00

Price Analysts Target

-
XYLO price consensus analysts' forecast is unknown

Price Most Recent Change

+16.63%
XYLO price was up +16.63% on Mar 6, 2025

Price YTD Change

+35.64%
XYLO price is up +35.64% since January 1st

Price 3-Year Change

-87.85%
XYLO price is down -87.85% over the past 3 years

Market cap

Market Cap

$3.59 M
XYLO market capitalization is $3.59 million

Market Cap 3-Year Change

-85.08%
XYLO market capitalization is down -85.08% over the past 3 years

Market Cap All-time High

$73.92 M
XYLO market capitalization is currently -95.14% below its historical high of $73.92 million

Market Cap Sector Rank

10.37%
XYLO market capitalization is higher than 10.37% of companies in Healthcare sector

Technical

Beta

1.68
XYLO beta is 1.68

200-day SMA

$4.07
XYLO price is currently +20.57% above its 200-day simple moving average

14-day RSI

54.18
XYLO 14-day relative strength index is 54.18

30-day Relative Volume

2.57
XYLO 30-day relative volume is 2.57

Dividend

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Events

Last Paid Dividend

$2.27
XYLO last dividend was $2.27 per share, with an ex-dividend date of December 19, 2022

Next Dividend

-
XYLO next dividend has not yet been announced

Dividend per share

Annual Dividend Per Share

-
XYLO annual dividend per share value is unknown

Annual Dividend Per Share Sector Rank

-
XYLO annual dividend per share is unknown

Annual Dividend Per Share 1-Year Change

-
XYLO annual dividend per share 1-year change is unknown

Annual Dividend Per Share 3-Year Change

-
XYLO annual dividend per share 3-year change is unknown

Dividend yield

Annual Dividend Yield

-
XYLO annual dividend yield value is unknown

Annual Dividend Yield Sector Rank

-
XYLO annual dividend yield is unknown

Other

Annual Payout Ratio

0.00%
XYLO annual payout ratio is 0.00%

Annual Dividends Paid

$0.00
XYLO annual dividends paid is $0.00

Annual FCF

-$7.99 M
XYLO annual free cash flow is -$7.99 million

Profitability

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Annual Revenue

$91.72 M
XYLO annual revenue is $91.72 million

Annual Revenue Analysts Estimate

$105.00 M
XYLO annual revenue is currently -12.64% lower than the consensus analysts' forecast

Annual Revenue 1-Year Change

-0.15%
XYLO annual revenue is down -0.15% year-on-year

Annual Revenue Sector Rank

56.86%
XYLO annual revenue is higher than 56.86% of companies in Healthcare sector

Profit

Annual Gross Profit

$11.84 M
XYLO annual gross profit is $11.84 million

Annual Gross Margin

12.91%
XYLO annual gross profit margin is 12.91%

Annual Operating Profit

-$10.81 M
XYLO annual operating income is -$10.81 million

Annual Operating Margin

-11.79%
XYLO annual operating profit margin is -11.79%

Annual Net Income

-$16.02 M
XYLO annual net profit is -$16.02 million

Annual Net Margin

-17.47%
XYLO annual net profit margin is -17.47%

EPS

Annual EPS

-$25.20
XYLO annual earnings per share is -$25.20

Annual EPS Analysts Estimate

$0.48
XYLO annual earnings per share is currently -5350.00% lower than the consensus analysts' forecast

Annual EPS 1-Year Change

-57.5%
XYLO annual earnings per share is down -57.5% year-on-year

Annual EPS Sector Rank

9.41%
XYLO annual earnings per share is higher than 9.41% of companies in Healthcare sector

ROA & ROE

Annual ROA

-19.84%
XYLO annual return on assets is -19.84%

Annual ROE

-36.79%
XYLO annual return on equity is -36.79%

EBIT & EBITDA

Annual EBIT

-$20.27 M
XYLO annual earnings before interest & taxes is -$20.27 million

Annual EBITDA

-$16.30 M
XYLO annual EBITDA is -$16.30 million

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
XYLO price to earnings ratio value is unknown

PE Ratio Sector Rank

-
XYLO price to earnings ratio is unknown

PB Ratio

PB Ratio

0.24
XYLO price to book ratio is 0.24

PB Ratio Sector Rank

20.13%
XYLO price to book ratio is higher than 20.13% of companies in Healthcare sector

PS Ratio

PS Ratio

-
XYLO price to sales ratio value is unknown

PS Ratio Sector Rank

-
XYLO price to sales ratio is unknown

Enterprise value

Enterprise Value

$3.41 M
XYLO enterprise value is $3.41 million

Enterprise Value Sector Rank

16.46%
XYLO enterprise value is higher than 16.46% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-
XYLO EV/EBITDA value is unknown

EV/EBITDA Sector Rank

-
XYLO EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Annual Current Ratio

1.08
XYLO annual current ratio is 1.08

Annual Quick Ratio

1.00
XYLO annual quick ratio is 1.00

Leverage

Annual Debt To Equity

0.39
XYLO annual debt to equity ratio is 0.39

Annual Interest Coverage Ratio

-13.23
XYLO annual interest coverage ratio is -13.23

Risk & Stability

Piotroski F-Score

-
XYLO piotroski f-score value is unknown

Altman Z-Score

-1.72
XYLO altman z-score is -1.72

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Annual Total Assets

$63.90 M
XYLO annual total assets is $63.90 million

Annual Non Current Assets

$32.23 M
XYLO annual long term assets is $32.23 million

Annual Current Assets

$31.67 M
XYLO annual total current assets is $31.67 million

Annual Cash & Cash Equivalents

$9.36 M
XYLO annual cash & cash equivalents is $9.36 million

Equity

Annual Book Value

$23.58 M
XYLO annual book value is $23.58 million

Annual Working Capital

$2.40 M
XYLO annual working capital is $2.40 million

Liabilities

Annual Total Liabilities

$31.46 M
XYLO annual total liabilities is $31.46 million

Annual Total Long Term Liabilities

$2.19 M
XYLO annual total long term liabilities is $2.19 million

Annual Current Liabilities

$29.27 M
XYLO annual total current liabilities is $29.27 million

Annual Accounts Payable

$13.25 M
XYLO annual accounts payable is $13.25 million

Debt

Annual Total Debt

$9.79 M
XYLO annual total debt is $9.79 million

Annual Total Debt 1-Year Change

-3.44%
XYLO annual total debt is down -3.44% year-on-year

Annual Long Term Debt

$702.00 K
XYLO annual long term debt is $702.00 thousand

Annual Short Term Debt

$9.08 M
XYLO annual short term debt is $9.08 million

Expenses

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Annual Total Expenses

$102.54 M
XYLO annual total expenses is $102.54 million

Annual Operating Expenses

$22.66 M
XYLO annual total operating expenses is $22.66 million

Annual Cost Of Goods Sold

$79.88 M
XYLO annual cost of goods sold is $79.88 million

Annual SGA

$16.77 M
XYLO annual SGA is $16.77 million

Annual D&A

$3.98 M
XYLO annual depreciation & amortization is $3.98 million

Annual Interest Expense

$1.53 M
XYLO annual interest expense is $1.53 million

Cash Flow

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Annual CFO

-$6.25 M
XYLO annual cash flow from operations is -$6.25 million

Annual CFO 1-Year Change

-10.45%
XYLO annual cash flow from operations is down -10.45% year-on-year

Annual CFI

-$1.44 M
XYLO annual cash flow from investing activities is -$1.44 million

Annual CFI 1-Year Change

+67.87%
XYLO annual cash flow from investing activities is up +67.87% year-on-year

Annual CFF

-$3.15 M
XYLO annual cash flow from financing activities is -$3.15 million

Annual CFF 1-Year Change

-158.21%
XYLO annual cash flow from financing activities is down -158.21% year-on-year

Free CashFlow

Annual FCF

-$7.99 M
XYLO annual free cash flow is -$7.99 million

Annual FCF 1-Year Change

-39.51%
XYLO annual free cash flow is down -39.51% year-on-year

CAPEX

Annual CAPEX

$1.75 M
XYLO annual capital expenditures is $1.75 million

Annual CAPEX 1-Year Change

+2260.81%
XYLO annual capital expenditures is up +2260.81% year-on-year

Institutional Ownership

Similar stocks

SPRC logo
SciSparc (SPRC)
NCNA logo
NuCana (NCNA)
TTNP logo
Titan Pharmaceuticals (TTNP)
KZIA logo
Kazia Therapeutics Limited (KZIA)
PBM logo
Psyence Biomedical (PBM)
CNSP logo
CNS Pharmaceuticals (CNSP)
GENE logo
Genetic Technologies Limited (GENE)
TTOO logo
T2 Biosystems (TTOO)
Syra Health Corp Class A (SYRA)

FAQ

  • What is the ticker symbol for Xylo Technologies?
  • Does Xylo Technologies pay dividends?
  • What sector is Xylo Technologies in?
  • What industry is Xylo Technologies in?
  • What country is Xylo Technologies based in?
  • Is Xylo Technologies in the S&P 500?
  • Is Xylo Technologies in the NASDAQ 100?
  • Is Xylo Technologies in the Dow Jones?
  • When was Xylo Technologies's last earnings report?
  • When does Xylo Technologies report earnings?

What is the ticker symbol for Xylo Technologies?

The ticker symbol for Xylo Technologies is NASDAQ:XYLO

Does Xylo Technologies pay dividends?

No, Xylo Technologies does not pay dividends

What sector is Xylo Technologies in?

Xylo Technologies is in the Healthcare sector

What industry is Xylo Technologies in?

Xylo Technologies is in the Medical Devices industry

What country is Xylo Technologies based in?

Xylo Technologies is headquartered in Israel

Is Xylo Technologies in the S&P 500?

No, Xylo Technologies is not included in the S&P 500 index

Is Xylo Technologies in the NASDAQ 100?

No, Xylo Technologies is not included in the NASDAQ 100 index

Is Xylo Technologies in the Dow Jones?

No, Xylo Technologies is not included in the Dow Jones index

When was Xylo Technologies's last earnings report?

Xylo Technologies's most recent earnings report was on Feb 28, 2025

When does Xylo Technologies report earnings?

The date for Xylo Technologies's next earnings report has not been announced yet